Low Frequency of HLA-B*15:02 in Northwest China: Implications for Carbamazepine-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Screening Strategies

Xu Wang, Ping Yang, Feng Rao, Longnan Wang, Fenglin Mou, Huimei Zhang, Qiuyan Chen, Zheng Yin, Yanzi Jing, Qiang Liu, Xianrui Xu, Qing Zhang

Open source

DOI
10.2147/pgpm.s621616
Published
2026-08
Container
Pharmacogenomics and Personalized Medicine
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/pgpm.s621616,
  title = {Low Frequency of HLA-B*15:02 in Northwest China: Implications for Carbamazepine-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Screening Strategies},
  author = {Xu Wang and Ping Yang and Feng Rao and Longnan Wang and Fenglin Mou and Huimei Zhang and Qiuyan Chen and Zheng Yin and Yanzi Jing and Qiang Liu and Xianrui Xu and Qing Zhang},
  year = {2026},
  journal = {Pharmacogenomics and Personalized Medicine},
  doi = {10.2147/pgpm.s621616},
  url = {https://doi.org/10.2147/pgpm.s621616}
}

RIS

TY  - JOUR
TI  - Low Frequency of HLA-B*15:02 in Northwest China: Implications for Carbamazepine-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Screening Strategies
AU  - Xu Wang
AU  - Ping Yang
AU  - Feng Rao
AU  - Longnan Wang
AU  - Fenglin Mou
AU  - Huimei Zhang
AU  - Qiuyan Chen
AU  - Zheng Yin
AU  - Yanzi Jing
AU  - Qiang Liu
AU  - Xianrui Xu
AU  - Qing Zhang
PY  - 2026
JO  - Pharmacogenomics and Personalized Medicine
DO  - 10.2147/pgpm.s621616
UR  - https://doi.org/10.2147/pgpm.s621616
ER  - 

APA

Wang, X., Yang, P., Rao, F., Wang, L., Mou, F., Zhang, H., Chen, Q., Yin, Z., Jing, Y., Liu, Q., Xu, X., & Zhang, Q. (2026). Low Frequency of HLA-B*15:02 in Northwest China: Implications for Carbamazepine-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Screening Strategies. Pharmacogenomics and Personalized Medicine. https://doi.org/10.2147/pgpm.s621616

Source records